Caption Management’s Novavax NVAX Stock Holding History

Caption Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-300,000	Closed	-$2.02M	–	1903
2025 Q4	$2.02M	Buy	300,000 +250,000	+500%	+$1.88M	0.01%	835
2025 Q3	$434K	Sell	50,000 -195,000	-80%	-$1.52M	﹤0.01%	1333
2025 Q2	$1.54M	Buy	245,000 +45,000	+23%	+$298K	0.02%	804
2025 Q1	$1.28M	Buy	200,000 +80,000	+67%	+$661K	0.01%	830
2024 Q4	$965K	Sell	120,000 -120,000	-50%	-$1.16M	0.01%	926
2024 Q3	$3.03M	Buy	+240,000	New	+$3.1M	0.05%	441
2021 Q2	–	Sell	-20,100	Closed	-$3.64M	–	1494
2021 Q1	$3.64M	Buy	+20,100	New	+$4.01M	0.08%	330
2020 Q1	–	Sell	-680,000	Closed	-$2.71M	–	1003
2019 Q4	$2.71M	Hold	680,000	–	–	0.09%	302
2019 Q3	$3.41M	Sell	680,000 -250,000	-27%	-$1.37M	0.18%	154
2019 Q2	$5.45M	Buy	930,000 +828,920	+820%	+$6.52M	0.27%	103
2019 Q1	$22.3M	Buy	+101,080	New	+$3.19M	1.23%	8

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Caption Management's NVAX Position: Q2 2026 in Review

Caption Management sold out of Novavax (NVAX) in Q2 2026, closing a stake of 148,155 shares — an estimated $1.33M sold.

Caption Management first reported a position in NVAX in Q4 2018 and held it in 7 quarters. The position peaked at $1.4M in Q1 2021. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Caption Management reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
Caption Management sold 148,155 Novavax shares in Q2 2026, an estimated $1.33M.
Caption Management first reported a position in Novavax in Q4 2018 and held it in 7 quarters.
Caption Management's Novavax position peaked at $1.4M in Q1 2021.
267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.